Faculty profile
Mark Carey
Back to facultyThis profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses and email address may be missing. Find their university profile.
Research
Latest papers
Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.
The Journal of pathology · 2026
The Development and Testing of a Patient Decision Aid for Individuals with Homologous Recombinant Proficient Ovarian Cancer Who Are Considering Niraparib Maintenance Therapy.
Current oncology (Toronto, Ont.) · 2024
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society · 2023
Latest funding
- $1,575,898
Refining Adjuvant treatment IN endometrial cancer Based On molecular features (RAINBO) No Specific Molecular Profile (NSMP)-ORANGE trial
CIHR · 2026 · Co-investigator
- $1,166,628
STRIVE Study: STRatIfication of Vulvar squamous cell carcinoma by HPV and p53 status to guide Excision
CIHR · 2024 · Co-investigator
- $761,175
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials - The MMRD-GREEN trial
CIHR · 2022 · Co-investigator
7 publications.
Dedifferentiation in endometrial cancer is associated with HLA-I silencing that may be restored by IFN-γ.
De Leo A, Wickenberg M, Grillini M, Coadǎ CA, Praveen Kumar P, Tong A, Key J, Kim H, Kommoss F, Carey M, Fu Y, Ceccarelli C, Tallini G, LaPointe P, Köbel M, Lee CH
The Development and Testing of a Patient Decision Aid for Individuals with Homologous Recombinant Proficient Ovarian Cancer Who Are Considering Niraparib Maintenance Therapy.
Hopkins L, Carey M, Brown L, McCrea S, Milne M, Tokaryk D, Stacey D
Impact of adjuvant chemotherapy on the overall survival of patients with advanced-stage low-grade serous ovarian carcinoma following primary cytoreductive surgery.
Nasioudis D, Wang X, Dhillon G, Latif N, Ko EM, Giuntoli RL, Gershenson D, Fader A, Carey M, Simpkins F
SWI/SNF-deficiency defines highly aggressive undifferentiated endometrial carcinoma.
Tessier-Cloutier B, Coatham M, Carey M, Nelson GS, Hamilton S, Lum A, Soslow RA, Stewart CJ, Postovit LM, Köbel M, Lee CH
Incorporating patient centered benefits as endpoints in randomized trials of maintenance therapies in advanced ovarian cancer: A position paper from the GCIG symptom benefit committee
Kurtz J-E, Gebski V, Sukhin V, Carey M, Kong I, Glasspool RM, Berek JS, de Paiva Batista M, Hall M, Kim J-W
Characterization of Mutational Status, Spheroid Formation, and Drug Response of a New Genomically-Stable Human Ovarian Clear Cell Carcinoma Cell Line, 105C
Kolendowski B, Valdes YR, Hirte H, Itamochi H, Lee W, Carey M, Shepherd TG, DiMattia GE
A brief mindfulness-based cognitive behavioral intervention improves sexual functioning versus wait-list control in women treated for gynecologic cancer.
Brotto LA, Erskine Y, Carey M, Ehlen T, Finlayson S, Heywood M, Kwon J, McAlpine J, Stuart G, Thomson S, Miller D
Refining Adjuvant treatment IN endometrial cancer Based On molecular features (RAINBO) No Specific Molecular Profile (NSMP)-ORANGE trial
Principal investigators: Parulekar, Wendy R; Ethier, Josee-Lyne
Keywords: Endocrine Therapy; Endometrial Cancer; International; Molecular Classification; Non-Inferiority; Phase Iii; Quality Of Life; Radiotherapy; Randomized
STRIVE Study: STRatIfication of Vulvar squamous cell carcinoma by HPV and p53 status to guide Excision
Principal investigators: Jamieson, Amy; Mcalpine, Jessica N
Keywords: De-Escalated Surgery; Human Papilloma Virus (Hpv); Molecular Stratification; P16 Immunohistochemistry (Ihc); Patient Reported Quality Of Life; Personalized Medicine; Prospective Clinical Trial; Surgical Margins; Tp53 Mutations/P53 Immunohistochemistry (Ihc); Vulvar Squamous Cell Carcinoma
RAINBO: Refining Adjuvant treatment IN endometrial cancer Based On molecular features, TransPORTEC platform trials - The MMRD-GREEN trial
Principal investigators: Parulekar, Wendy R; Welch, Stephen A
Keywords: Adjuvant Therapy; Endometrial Cancer; Immunotherapy; Mismatch Repair Deficiency; Molecular Classification; Personalized Medicine; Predictive Biomarkers; Quality Of Life; Randomized Phase Iii Trial
Deconvoluting Prognostic and Targetable Features of Endometrioid Ovarian Carcinomas of No Specific Molecular Profile
Principal investigators: Anglesio, Michael S; Carey, Mark S; Koebel, Martin; Talhouk, Aline
Keywords: Endometrioid Ovarian Cancer; Genomics; Gynecological Cancer; Immunohistochemistry; Mouse Model; Prognostic Models; Xenografts
Omics, Histopathology and AI: An Integrative Approach for Biomarker Discovery in Ovarian Cancer
Principal investigators: Gilks, Cyril B; Bashashati, Ali; Salcudean, Septimiu E
Keywords: Artificial Intelligence; Biomarkers; Computational Biology; Computational Pathology; Genomics; Image Processing; Machine Learning; Ovarian Cancer; Pathology
Developing a National-wide research network for the study of rare cancers: the example of low-grade serous ovarian cancer.
Principal investigators: Carey, Mark S
Keywords: Knowledge Translation; Low-Grade Serous Ovarian Cancer; National Outcomes Database; National Research Network; New Clinical Guidelines; Patient And Physician Engagement; Treatment Outcomes
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Obstetrics and Gynecology
- Oncology
- Nursing Sciences
- Cell Biology
- Other
Co-authors at University of British Columbia, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
Gavin Stuart
Faculty
1 shared papers, latest 2012
Janice Kwon
Obstetrics and Gynecology
1 shared papers, latest 2012
Paul LaPointe
Cell Biology
1 shared papers, latest 2026
Basile Tessier-Cloutier
Obstetrics and Gynecology
1 shared papers, latest 2021
Iwa Kong
Oncology
1 shared papers, latest 2021
Holger Hirte
Oncology
1 shared papers, latest 2020
Dawn Stacey
Nursing Sciences
1 shared papers, latest 2024
Jessica Mcalpine
Obstetrics and Gynecology
1 shared papers, latest 2012
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.